Mivocabtagene Autoleucel (Kyverna Therapeutics Inc.) for Stiff Person Syndrome

An autologous CD19-directed chimeric antigen receptor (CAR) T-cell therapy under investigation for the treatment of stiff person syndrome (SPS).